Global Lysosomal Storage Diseases Market 2014-2018

Information about Global Lysosomal Storage Diseases Market 2014-2018

Published on August 8, 2014

Author: victoriaernest

Source: authorstream.com

Content

Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Order this report by calling +1 888 391 5441 or Send an email to [email protected] with your contact details and questions if any. 1 © SandlerResearch.org/ Contact [email protected] Published: July 2014 Single User PDF: US$ 2500 Corporate User PDF: US$ 3500 No. of Pages : 54 Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 The term lysosomal storage diseases refers to a group of rare inherited disorders caused by the deficiency of lysosomal enzymes, activator proteins, proteins required for normal post-translational modification of lysosomal enzymes or proteins required for intracellular transport between lysosome and other cellular compartments. These deficiencies result in deficient enzymatic activity which, in turn, leads to accumulation of partially digested or undigested macromolecules inside the cell. The clinical manifestations of lysosomal storage diseases depend on the type of substrate stored, cell types affected by this storage, and resulting organ involvement. Due to the high variability of these components, the clinical manifestations of even a single disease vary from person to person. These symptoms also vary between members of the same family with identical mutations. 2 © SandlerResearch.org/ Contact [email protected] Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=21227 . Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 The age of onset also varies for lysosomal storage diseases depending on the rate of substrate accumulation. Lysosomal storage diseases are classified on the basis of the substrate being accumulated or on the type of molecular defect associated with the disease. Neuronal ceroid-lipofuscinoses vary from classical lysosomal storage diseases where the component that gets accumulated is mitochondrial ATP synthase subunit C or sphingolipid activator proteins A and D. Analysts forecast the Global Lysosomal Storage Diseases market will grow at a CAGR of 10.01 percent over the period 2013-2018. 3 © SandlerResearch.org/ Contact [email protected] Complete Report is Available @ http://www.sandlerresearch.org/global-lysosomal-storage-diseases-market-2014-2018.html . Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 The report recognizes the following companies as the key players in the Global Lysosomal Storage Diseases market: Actelion Pharmaceuticals Ltd., BioMarin Pharmaceutical Inc., Genzyme Corp. and Shire plc. Other Prominent Vendors in the market are: Mylan , Pfizer, Protalix , Raptor, Recordati , Sigma-Tau One of the prominent trends in this market is an increase in awareness among regulatory authorities. Regulatory bodies are steadily working toward developing guidelines and providing assistance to drug manufacturers to promote research in this area. 4 © SandlerResearch.org/ Contact [email protected] Get discount on the Report @ http://www.sandlerresearch.org/discount?rname=21227 . Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Covered in this Report This report covers the present scenario and the growth prospects of the Global Lysosomal Storage Diseases market for the period 2014-2018. To calculate the market size, the report considers revenue from the sales of various drugs available in the market for the management of different types of lysosomal storage diseases, which include: • Gaucher disease • Fabry disease • Mucopolysaccharidosis • Pompe disease • Cystinosis • NPC 5 © SandlerResearch.org/ Contact [email protected] Complete Report is Available @ http://www.sandlerresearch.org/global-lysosomal-storage-diseases-market-2014-2018.html . Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Global Lysosomal Storage Diseases Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Lysosomal Storage Diseases market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. 6 © SandlerResearch.org/ Contact [email protected] Inquire Before buying the Report @ http://www.sandlerresearch.org/inquire-before-buying?rname=21227 . Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Key Regions Americas EMEA APAC Key Vendors Actelion Pharmaceuticals Ltd. BioMarin Pharmaceutical Inc. Genzyme Corp. Shire plc 7 © SandlerResearch.org/ Contact [email protected] Browse All Reports on Pharmaceutical Market Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Other Prominent Vendors Mylan Pfizer Protalix Raptor Recordati Sigma-Tau 8 © SandlerResearch.org/ Contact [email protected] Inquire Before buying the Report @ http://www.sandlerresearch.org/inquire-before-buying?rname=21227 . Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Key Market Driver • Special Provisions for Orphan Drugs Key Market Challenge • Increase in Generic Erosion Key Market Trend • Fierce Market Competition 9 © SandlerResearch.org/ Contact [email protected] Browse All Reports on Pharmaceutical Market Global Lysosomal Storage Diseases Market 2014-2018: Global Lysosomal Storage Diseases Market 2014-2018 Key Questions Answered in this Report What will the market size be in 2018 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? 10 © SandlerResearch.org/ Contact [email protected] Single User License of the Report is Available at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=21227 . Find Us.: 11 © SandlerResearch.org/ Contact [email protected] Reach us at + 1 888 391 5441 | [email protected] Find Us.

Related presentations


Other presentations created by victoriaernest

LBS Market in India 2014-2018
07. 08. 2014
0 views

LBS Market in India 2014-2018

Absorbents Markets in China
21. 08. 2014
0 views

Absorbents Markets in China

Methylbenzene Markets in China
21. 08. 2014
0 views

Methylbenzene Markets in China

Global Asthma Market 2014-2018
03. 09. 2014
0 views

Global Asthma Market 2014-2018